drugset / Trial / NCT05181124

Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

NCT05181124

Phase 1 Completed 88 enrolled Onconic Therapeutics Inc.
Non-randomizedFactorialOpen-labelTreatment

Summary

To evaluate the effect of coadministration of aceclofenac, meloxicam and naproxen on pharmacokinetic interactions and safety of JP-1366 in healthy Korean subjects and to compare the pharmacokinetic nature and safety of JP-1366 between healthy Korean and Caucasian.

Timeline

Start
2021-03-05
Primary completion
2021-03-15
Completion
2021-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Aceclofenac Small molecule
Subject JP-1366 Unknown
Subject Meloxicam Small molecule
Subject Naproxen Small molecule